Matthias Endres

Professor Matthias Endres is a leading academic at Charité - Universitätsmedizin Berlin's School of Medicine, Department of Neurology. He coordinates major multicenter studies including the DZNE Mechanisms of Dementia After Stroke (DEMDAS), PRAISE (acute coronary syndrome in stroke patients), DELCODE (longitudinal cognitive impairment), and chemotherapy-induced neurotoxicity prevention projects.

• DEMDAS: Investigates post-stroke dementia mechanisms using cardiac biomarkers and autoantibody analysis
• PRAISE: First DZHK-DZNE collaboration identifying troponin thresholds for myocardial infarction in stroke patients
• BASE-II: 7-year longitudinal analysis linking subclinical cardiac injury to cognitive decline

His research integrates neurology, cardiovascular medicine, and oncological neurotoxicity through translational approaches. Current work focuses on troponin as a prognostic biomarker, anti-NMDA receptor antibodies, and novel neuroprotective compounds. While no formal awards are listed, his leadership in cross-disciplinary studies (DZNE/DZHK) demonstrates significant scientific impact.

Endres' publications (2022-2024) reveal consistent focus on biomarker validation across three domains: post-stroke cognitive trajectories, cardiac-neurological interactions, and chemotherapy-induced neurotoxicity. His team employs advanced imaging techniques (MRI white matter hyperintensities), biochemical analysis, and clinical trial frameworks to address these critical research questions.